Issue 43, 2022, Issue in Progress

Scalemic myrionsumamide A, tetracyclic skeleton alkaloids from Myrioneuron effusum

Abstract

Investigation of the alkaloids from Myrioneuron effusum leads to the isolation of myrionsumamide A (1), a pair of enantiomeric alkaloids with an unprecedented tetracyclic system skeleton. These two alkaloids were separated by chiral HPLC with a ratio of 3 : 5 from the scalemic mixture. Their structures including absolute configurations were determined by NMR spectroscopy, X-ray diffraction data and ECD calculations. Both (+)-1 and (−)-1 showed antibacterial activity against Staphylococcus aureus with MIC at 7.81 μg ml−1.

Graphical abstract: Scalemic myrionsumamide A, tetracyclic skeleton alkaloids from Myrioneuron effusum

Supplementary files

Article information

Article type
Paper
Submitted
26 Aug 2022
Accepted
23 Sep 2022
First published
03 Oct 2022
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2022,12, 28147-28151

Scalemic myrionsumamide A, tetracyclic skeleton alkaloids from Myrioneuron effusum

J. Zhang, M. Cao, Y. Zhang, X. Li, Y. Gu, X. Li, Y. Di and X. Hao, RSC Adv., 2022, 12, 28147 DOI: 10.1039/D2RA05342J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements